Article title: Osteoporosis: NWHIC
Conditions: Osteoporosis, Pregnancy-associated osteoporosis
Are women more affected by osteoporosis than men?
What are the risk factors for osteoporosis?
What is pregnancy-associated osteoporosis?
Will I suffer bone loss during breastfeeding?
How would I know if I might have osteoporosis?
How can I protect myself from having osteoporosis?
How is osteoporosis treated?
Osteoporosis, which means "porous bones," is a condition of excessive skeletal fragility resulting in weakened bones that break easily. A combination of genetic, dietary, hormonal, age-related, and lifestyle factors all contribute to this condition. Osteoporosis usually progresses painlessly until a fracture occurs, which is usually in the hip, spine, or wrist.
Overall, approximately eight million American women and 2 million men have osteoporosis. Women are four times more likely than men to develop osteoporosis because of the loss of estrogen at menopause. (Estrogen blocks or slows down bone loss.) Over half of all women over the age of 65 have osteoporosis. Even though osteoporosis is often thought of as a disease that only affects older people, it can strike at any age.
Osteoporosis leads to 1.5 million fractures, or breaks, per year, mostly in the hip, spine and wrist, and costs $14 billion annually. One in two women over the age of 50 will suffer an osteoporosis-related fracture.
Factors that can increase your chances of developing osteoporosis include:
a small, thin body frame;
a family history of osteoporosis;
postmenopausal status or advanced age;
Caucasian or Asian race;
abnormal absence of menstrual periods;
anorexia nervosa or bulimia;
low testosterone levels in men;
diet low in dairy products or other sources of calcium and vitamin D;
long-term use of glucocorticoids (medications prescribed for many diseases, including arthritis, asthma, and lupus) anti-seizure medications; gonadotropin releasing hormone for treatment of endometriosis; aluminum-containing antacids; certain cancer treatments; and excessive thyroid hormone;
cigarette smoking; and
excessive use of alcohol and high salt, protein, and caffeine intake.
Pregnancy-associated osteoporosis is believed to be a rare condition that is usually found in the third trimester or postpartum period. It usually occurs during the first pregnancy, is temporary, and does not recur. Women affected usually complain of back pain, have a loss of height, and have vertebral fractures. In 1996, there had been 80 cases reported in the medical literature. Researchers do not know if this condition occurs as a result of pregnancy or because of pre-existing conditions in a pregnant woman. Factors that may cause this condition, such as genetic factors or steroid use, are being studied. Even though there is stress on a pregnant woman’s calcium supply and calcium excretion is increased by frequent urination, other changes during pregnancy, like increases in estrogen and weight gain, may actually help bone density.
There is much more to be learned about how a woman’s bone density is affected by pregnancy.
Although significant amounts of bone mineral can be lost during breastfeeding, this loss tends to be temporary. Studies consistently have shown that when women have bone loss during lactation, they recover full bone density within six months after weaning.
A family medical history and bone mass measurements are part of a complete assessment. Often a bone fracture is the first sign of osteoporosis. Ask your doctor to help you better understand your own risk and become aware of prevention and treatment options.
Routine x-rays can't detect osteoporosis until it's quite advanced, but other radiological methods can. The Food and Drug Administration (FDA) has approved several kinds of devices to estimate bone density. Most require far less radiation than a chest x-ray. Doctors consider a patient's medical history and risk factors in deciding who should have a bone density test. Readings are compared to a standard for the patient's age, sex and body size. Different parts of the skeleton may be measured, and low density at any site is worrisome. Bone density tests are useful for confirming a diagnosis of osteoporosis if a person has already had a suspicious fracture, or for detecting low bone density so that preventive steps can be taken.
Osteoporosis is usually preventable. Females need to take steps to protect the health of their bones while they are still children, and on through their teenage and young adult years. Building strong bones at a young age will lessen the effect of the natural bone loss that begins to occur around age 30.
Eat foods rich in calcium and vitamin D, such as low-fat milk, yogurt, cheese, fish with edible bones like salmon and sardines, and dark green, leafy vegetables, like kale and broccoli. Do weight-bearing exercise, such as walking, jogging, hiking, playing tennis, and stair climbing. Exercise builds bone and muscle strength and helps prevent bone loss and improves coordination to prevent falls. It also helps older people stay active and mobile. Weight-bearing exercises, done on a regular basis, are best for preventing osteoporosis. Always check with your doctor before starting an exercise program. If you are postmenopausal, consider estrogen replacement. Consider using calcium supplements, but discuss the choice of supplements with your doctor first. Don't smoke. Limit alcoholic beverages.
What is the optimal calcium intake for women in different stages of their life?
Diet, hormones, drugs, age and genetic factors all influence the amount of calcium required for optimal skeletal health. Recommendations vary slightly. Based upon the most recent recommendations from the National Academy of Sciences (1997) on optimal daily calcium intake, the following amounts are recommended for these different age groups:
Recommended daily intake of calcium for women who are pregnant or lactating.
**NOTE: The National Institutes of Health Consensus Conference and The National Osteoporosis Foundation support a higher calcium intake of 1,500 milligrams per day for postmenopausal women not taking estrogen and adults 65 years or older.
The guidelines are based on calcium received through diet and through calcium supplements. Calcium intake up to 2,000 mg/day appears to be safe in most individuals. Adequate Vitamin D is essential for optimal calcium absorption. Most people receive enough Vitamin D through sunlight. You can also get this vitamin from supplements, as well as from cereal and milk fortified with Vitamin D. If supplements are necessary, no more than 800 International Units (IU) mg/day is recommended.
Lifestyle changes and medical treatment are part of a total program to prevent future fractures. A diet rich in calcium, daily exercise, and drug therapy are treatment options. Good posture and prevention of falls are important in reducing the chance of being injured.
Under FDA guidelines, drugs to treat osteoporosis must be shown to preserve or increase bone mass and maintain bone quality in order to reduce the risk of fractures. The following drugs are approved by the FDA for the treatment or prevention of osteoporosis:
Estrogen – Estrogen Replacement Therapy (ERT) is approved for both prevention and treatment of osteoporosis. It reduces bone loss, increases bone density in the spine and hip, and reduces the risk of fractures in postmenopausal women. Doctors prescribe ERT in combination with the hormone progestin (called hormone replacement therapy or HRT) to reduce the risk of developing cancer in the lining of the uterus. HRT has shown to be effective at reducing the symptoms of menopause and having beneficial effects on both the skeleton and heart.
Alendronate (Fosamax®) – This drug belongs to a class of drugs called biophosphonates and is approved for both prevention and treatment of osteoporosis. It is used to treat bone loss from the long-term use of osteoporosis-causing medications and is used for osteoporosis in men. In postmenopausal women, it has shown to be effective at reducing bone loss, increasing bone density in the spine and hip, and reducing the risk of spine and hip fractures.
Risedronate (Actonel®) – Like Alendronate, this drug also is a biophosphonate and is approved for both prevention and treatment of osteoporosis, for bone loss from the long-term use of osteoporosis-causing medications, and for osteoporosis in men. It has been shown to slow bone loss, increase bone density, and reduce the risk of spine and non-spine fractures.
Calcitonin (Miacalcin®) - Calcitonin is a naturally occurring hormone involved in calcium regulation and bone metabolism. Calcitonin can be injected or taken as a nasal spray. In women who are at least five years beyond menopause, it slows bone loss and increases spinal bone density. Women report that it also eases pain associated with bone fractures.
Raloxifene (Evista®) – This drug is a selective estrogen receptor modulator (SERM) that has many estrogen-like properties. It is approved for prevention and treatment of osteoporosis and can prevent bone loss at the spine, hip, and other areas of the body. Studies have shown that it can decrease the rate of vertebral fractures by 30-50%.
Other treatments are being studied. They include new biophosphonates and SERMs, Vitamin D metabolites, parathyroid hormone, and sodium fluoride. A woman and her doctor need to carefully weigh the risks and benefits of these treatment options.
For more information...
You can find out more about osteoporosis by contacting the National Women’s Health Information Center (800-994-9662) or the following organizations:
National Osteoporosis Foundation
Phone: (877) 868-4520
Internet Address: http://www.nof.org/
Osteoporosis and Related Bone Diseases National Resource
Phone: (800) 624-2663
Internet Address: http://www.osteo.org/
Food and Drug Administration
Phone: (888) 463-6332
Internet Address: http://www.fda.gov/
National Institute of Arthritis and Musculoskeletal and Skin
Phone: (301) 496-8188
Internet Address: http://www.nih.gov/niams/
National Institute on Aging
Phone: (800) 222-2225
Internet Address: http://www.nih.gov/nia/
All material contained in the FAQs is free of copyright restrictions, and may be copied, reproduced, or duplicated without permission of the Office on Women's Health in the Department of Health and Human Services; citation of the sources is appreciated.
Publication date: April 2001
Medical Tools & Articles:
- Risk Factor Center
- Medical Statistics Center
- Medical Treatment Center
- Prevention Center
- Medical Tests Center